Le Lézard
Classified in: Health, Business
Subjects: ERN, ACC

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT NOVEMBER 2023


Zinzino group revenue increased with a total of 24 %, compared with the previous year.

GOTHENBURG, Sweden, Dec. 5, 2023 /PRNewswire/ -- The revenue in November for Zinzino's sales markets increased by 24 % and amounted to SEK 199.6 (161.2) million. Faun Pharma's external sales increased by 29 % and amounted to SEK 7.6 (5.9) million. Overall, the Group increased revenues by 24 % to SEK 207.2 (167.1) million compared with the previous year.

Accumulated revenue for January ? November 2023 increased by 22 % to SEK 1609.6 (1314.2) million.

Revenues were distributed as follows:

Regions,MSEK

23-Nov

22-Nov

Change

YTD 2023

YTD 2022

Change

The Nordics

29.3

28.4

3 %

274.9

292.3

-6 %

Central Europe

50.9

38.6

32 %

399.7

263,0

52 %

East Europe

49.8

46.1

8 %

362.3

314.2

15 %

South & West Europe

34.5

19.6

76 %

241,0

149.7

61 %

The Baltics

14.8

11.1

33 %

91.7

70.7

30 %

North America

12.6

8,0

58 %

97.5

71.6

36 %

Asia-Pacific

6.2

7.9

-22 %

45.8

71.7

-36 %

Africa

1.5

1.5

0 %

11.7

8.8

33 %

Zinzino

199.6

161.2

24 %

1524.6

1 242,0

23 %

Faun Pharma

7.6

5.9

29 %

85,0

72.2

18 %

Zinzino Group

207.2

167.1

24 %

1609.6

1314.2

22 %

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
[email protected]

Certified Adviser:
Carnegie Investment Bank AB (publ)

The following files are available for download:

https://mb.cision.com/Public/10976/3887912/a6e5e88b819bbed1.pdf

2311 Pressrelease Salesreport EN

 


These press releases may also interest you

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 3 2024- Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the interim...

2 mai 2024
The report titled "Muscle Stimulator Market by Technique (Burst Mode Alternating Current, Functional Electrical Stimulation, Interferential), Modality (Handheld, Portable, Table Top), Area, Application, End-User - Global Forecast 2024-2030" is now...

2 mai 2024
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announce that they have...

2 mai 2024
The United States of America and ReNew Health Group LLC have settled a nursing home whistleblower claim involving allegations that the nursing home chain submitted false Medicare claims. We need transparency and accountability in our nursing homes....



News published on and distributed by: